The Piracetam global buyers list market encompasses pharmaceutical manufacturers, generic-drug companies, API distributors, contract manufacturers, research organizations, and other qualified organizations involved in the regulated procurement of piracetam.

Piracetam is a small-molecule pharmaceutical substance with the chemical formula C₆H₁₀N₂O₂, molecular weight approximately 142.16 g/mol, and CAS No. 7491-74-9. It is also known by chemical names including 2-(2-oxopyrrolidin-1-yl)acetamide.

For companies developing a piracetam buyers database, the most useful approach is not simply collecting company names. A high-quality buyer profile should identify the organization’s business type, market served, regulatory requirements, purchasing specifications, dosage-form requirements, and ability to import or manufacture pharmaceutical products.

Important: Piracetam’s regulatory status differs substantially between markets. Buyers and suppliers should verify applicable national requirements before initiating commercial transactions. In the United States, for example, FDA materials indicate that piracetam is not an FDA-approved medical or dietary ingredient, while it is an authorized medicine in certain other jurisdictions.

What Is Piracetam?

Piracetam is a synthetic compound belonging to the racetam family and is classified as a pharmaceutical active substance. The National Institute of Standards and Technology identifies its CAS Registry Number as 7491-74-9 and its molecular formula as C₆H₁₀N₂O₂.

Piracetam has been used in pharmaceutical products in various international markets. For example, pharmaceutical API information from Polpharma identifies piracetam as a commercial API and describes formulations including oral and injectable products.

Its therapeutic and regulatory positioning should not be generalized worldwide. The European Medicines Agency maintains regulatory information concerning nationally authorized medicinal products containing piracetam, demonstrating that its status is market-specific.

Key Piracetam Identification Data

Specification	Information
Generic name	Piracetam
CAS Number	7491-74-9
Molecular formula	C₆H₁₀N₂O₂
Molecular weight	Approximately 142.16 g/mol
Chemical name	2-(2-Oxopyrrolidin-1-yl)acetamide
Pharmaceutical category	CNS-related pharmaceutical / racetam
Common procurement form	Pharmaceutical API
Typical buyer sectors	Pharmaceutical manufacturing, generic medicines, R&D, API distribution

Who Are the Global Buyers of Piracetam?

A useful Piracetam global buyers list should segment prospects according to their purchasing role rather than treating every pharmaceutical company as an equivalent buyer.

1. Pharmaceutical Manufacturers

Pharmaceutical manufacturers are among the most important potential buyers of piracetam API.

These organizations may purchase piracetam for:

Generic pharmaceutical production
Finished-dose tablets
Capsules
Oral solutions or syrups
Injectable formulations
Regional pharmaceutical portfolios
Product development and reformulation

The purchasing requirements of pharmaceutical manufacturers generally include documentation, analytical specifications, batch consistency, manufacturing controls, and regulatory support.

2. Generic Drug Manufacturers

Generic-drug companies may source piracetam API when developing or manufacturing products for markets where piracetam is authorized.

Potential buyers can include:

Generic pharmaceutical manufacturers
Regional drug companies
Established pharmaceutical license holders
Companies producing hospital medicines
Manufacturers serving specialty therapeutic categories

Because regulatory approval varies by jurisdiction, buyer qualification should include verification of the intended market and product authorization pathway.

3. Pharmaceutical API Distributors

API distributors can represent an important part of the international piracetam supply chain.

These companies may purchase material in commercial quantities and distribute it to:

Pharmaceutical manufacturers
Contract manufacturers
Formulation companies
Regional drug producers
Qualified institutional customers

For distributors, important supplier-selection factors can include packaging flexibility, documentation, batch traceability, supply continuity, and export capabilities.

4. Contract Manufacturing Organizations

CMOs and CDMOs may procure piracetam for customers developing or manufacturing finished pharmaceutical products.

Their purchasing teams commonly evaluate:

API quality
Manufacturing-site qualifications
Technical documentation
Analytical methods
Supply reliability
Batch-to-batch consistency
Packaging requirements
Regulatory documentation

5. Pharmaceutical Research and Development Organizations

Qualified R&D organizations may require piracetam for pharmaceutical development, analytical work, formulation research, or reference-standard activities.

However, research-use material should be clearly distinguished from material intended for pharmaceutical manufacturing.

For example, the European Directorate for the Quality of Medicines identifies piracetam laboratory material for scientific research, technical testing, and analysis and explicitly distinguishes such material from food, drug, or home use.

6. Academic and Institutional Research Buyers

Universities, laboratories, analytical organizations, and research institutions can also appear in a broader piracetam buyer database.

These buyers may require:

Research quantities
Analytical standards
Reference materials
Impurity standards
Method-development materials
Laboratory-grade substances

Such purchases should be handled according to the applicable institutional and regulatory requirements.

Major Buyer Markets for Piracetam

International demand should be evaluated market by market because the legal status and permitted uses of piracetam differ across jurisdictions.

A useful buyer research strategy can segment prospects into:

Europe

European pharmaceutical companies and distributors may be relevant prospects because piracetam is included in the European regulatory framework for nationally authorized medicinal products.

Potential buyer categories include:

Pharmaceutical manufacturers
Generic-drug companies
API distributors
Contract manufacturers
Pharmaceutical wholesalers
R&D organizations

Asia-Pacific

Asia-Pacific represents a diverse pharmaceutical market in which regulatory requirements and product registrations vary considerably between countries.

Buyer research can focus on:

Generic pharmaceutical manufacturers
Local marketing authorization holders
API importers
Pharmaceutical distributors
Contract manufacturers
Hospital-product suppliers

For example, a Philippine FDA verification record identifies registered piracetam finished products, illustrating the importance of country-specific regulatory verification when evaluating prospective buyers.

Latin America

Potential buyers may include:

Generic pharmaceutical companies
Pharmaceutical importers
Regional distributors
Contract manufacturers
Finished-dose manufacturers

Supplier outreach should be based on each country’s pharmaceutical registration and import requirements rather than assuming that authorization in another market automatically applies.

Middle East and Africa

Buyer opportunities can include:

Pharmaceutical manufacturers
Medicine importers
Regional distributors
Hospital-supply companies
Contract manufacturing organizations

Due diligence is particularly important when assessing whether a company is legally permitted to import or manufacture products containing piracetam.

North America

North American demand requires careful regulatory screening.

The FDA has stated that piracetam is not approved for medical or dietary use in the United States, and FDA enforcement materials have addressed products marketed with piracetam.

Consequently, businesses targeting U.S. prospects should distinguish legitimate pharmaceutical, research, analytical, and regulatory activities from prohibited or unsupported consumer-health marketing.

What Do Piracetam Buyers Look for From Suppliers?

A professional buyer normally evaluates more than price.

1. API Quality

Quality specifications may include:

Assay
Identification
Related substances
Residual solvents
Water content
Heavy metals or elemental impurities where applicable
Microbiological specifications where applicable
Particle characteristics
Stability data

The exact specification should be agreed upon according to the intended pharmaceutical application and applicable pharmacopoeial or regulatory requirements.

2. Regulatory Documentation

Qualified pharmaceutical buyers may request documentation such as:

Certificate of Analysis
Safety Data Sheet
Manufacturing information
Batch documentation
Specification sheet
Stability information
GMP-related documentation
Drug Master File support where applicable
Pharmacopoeial compliance information
Certificates of origin
Export documentation

The appropriate document package depends on the destination market and intended use.

3. Pharmacopoeial Compliance

Pharmacopoeial quality can be a significant procurement consideration.

Piracetam is represented in European pharmaceutical reference-standard resources, and pharmaceutical specifications may need to align with the applicable pharmacopoeial monograph or customer specification.

Suppliers should avoid claiming USP, EP, BP, GMP, CEP, DMF, or other regulatory status unless the relevant documentation genuinely supports the claim.

4. Consistent Supply

Commercial pharmaceutical buyers often prioritize:

Reliable production capacity
Consistent batch quality
Stable packaging
Predictable lead times
Export experience
Technical support
Long-term supply agreements

For a global buyer, supply continuity can be just as important as the initial quotation.

5. Packaging

Piracetam buyers may require different packaging configurations depending on order size and manufacturing process.

Commercial discussions can cover:

Inner packaging
Drum or fiber packaging
Pharmaceutical-grade liners
Bulk packaging
Customized labeling
Neutral packaging
Export cartons
Customer-specific packaging

Packaging must comply with applicable transport, storage, and pharmaceutical-quality requirements.

How to Build a High-Quality Piracetam Global Buyers List

A useful buyer database should prioritize verified commercial relevance over the sheer number of companies.

Step 1: Identify the Buyer Type

Classify each prospect as:

API buyer
Pharmaceutical manufacturer
Generic-drug manufacturer
Distributor
Importer
CMO/CDMO
R&D organization
Analytical laboratory
Institutional buyer

Step 2: Confirm Product Relevance

Look for evidence that the company works with:

Piracetam
CNS pharmaceutical products
Generic medicines
Racetam-related pharmaceutical products
Pharmaceutical APIs
Contract manufacturing
Relevant therapeutic categories

Step 3: Verify the Destination Market

Determine whether the buyer operates in a jurisdiction where the intended piracetam product has an appropriate regulatory pathway.

Health Canada’s framework, for example, explains that prescription status depends on factors including the need for practitioner supervision, uncertainty concerning use or effects, and potential risks to health.

Step 4: Identify the Correct Procurement Contact

The most relevant B2B contacts may include:

Procurement Manager
Strategic Sourcing Manager
API Purchasing Manager
Purchase Manager
Supply Chain Manager
R&D Manager
Formulation Manager
Business Development Manager
Technical Procurement Manager
Regulatory Affairs Manager

A high-quality database should prioritize business relevance and verified professional information rather than indiscriminately collecting personal contact details.

Step 5: Assess Purchasing Potential

Useful qualification fields include:

Buyer Data Field	Purpose
Company name	Identifies the organization
Country	Determines market requirements
Buyer category	Defines purchasing role
Product interest	Confirms piracetam relevance
Intended application	Helps determine technical requirements
Estimated purchase volume	Supports quotation strategy
Required grade	Aligns product specifications
Regulatory market	Determines documentation needs
Packaging preference	Supports commercial planning
Procurement contact	Enables professional outreach
Website	Supports company verification

Piracetam Buyer Qualification Checklist

Before treating a company as a qualified buyer, suppliers should evaluate:

Is the organization a legitimate pharmaceutical or research business?
Does it have a documented need for piracetam?
Is the intended use legally permitted in the destination market?
Does the company have appropriate import or manufacturing authorization where required?
What grade and specification does it require?
What documentation does it need?
What quantity does it purchase?
Does it require recurring supply?
What packaging format is appropriate?
Does it have a qualified procurement or technical contact?

This approach produces a substantially more useful Piracetam buyers database than a generic directory of pharmaceutical companies.

How Suppliers Can Attract Qualified Piracetam Buyers

A strong B2B landing page should answer the questions procurement teams ask before submitting an inquiry.

Content Strategy for Piracetam Buyer Acquisition

For SEO and Answer Engine Optimization, a piracetam buyer page should cover closely related search intent rather than repeating the target keyword unnaturally.

High-Value Topics

What is piracetam?
What is the CAS number of piracetam?
Who buys piracetam API?
Where is piracetam used?
How do pharmaceutical companies source piracetam?
What documents are required for piracetam API procurement?
How should piracetam suppliers qualify international buyers?
What factors affect piracetam API sourcing?
How can pharmaceutical companies evaluate piracetam suppliers?
What regulatory considerations apply to piracetam?

This structure helps search engines and answer engines understand the commercial and informational context of the page.

Piracetam Global Buyers List: Key Procurement Considerations

The global piracetam market should be approached as a regulated pharmaceutical B2B sourcing opportunity, not as a general consumer supplement market.

A credible supplier should be prepared to discuss:

Product identity — Piracetam, CAS 7491-74-9.
Quality specifications — Assay, impurities, physical properties, and applicable standards.
Manufacturing controls — Appropriate quality systems and documentation.
Regulatory status — Requirements for the buyer’s specific destination market.
Intended use — Pharmaceutical manufacturing, research, analytical work, or another permitted application.
Documentation — COA, SDS, specifications, and applicable regulatory documents.
Commercial supply — MOQ, packaging, production capacity, and logistics.
Technical support — Analytical and regulatory assistance where available.

Frequently Asked Questions About Piracetam Global Buyers

What is the CAS number of Piracetam?

The CAS Registry Number for piracetam is 7491-74-9. Its molecular formula is C₆H₁₀N₂O₂ and its molecular weight is approximately 142.16 g/mol.

Who are the main buyers of Piracetam API?

Potential buyers include pharmaceutical manufacturers, generic-drug companies, API distributors, contract manufacturers, pharmaceutical R&D organizations, and qualified analytical or research institutions.

Is Piracetam approved worldwide?

No. Piracetam’s regulatory status varies by jurisdiction. It is authorized for pharmaceutical use in certain markets, while other jurisdictions have different restrictions. The FDA, for example, states that piracetam is not FDA-approved for medical or dietary use in the United States.

What documents do Piracetam buyers commonly request?

Depending on the market and intended use, buyers may request a Certificate of Analysis, specification sheet, SDS, manufacturing information, GMP-related documentation, stability information, certificates of origin, and applicable regulatory files.

What should suppliers include in a Piracetam buyers list?

A professional buyer database should include company name, country, buyer type, product relevance, intended application, regulatory market, purchasing requirements, estimated demand where legitimately available, and verified business contact information.

How can pharmaceutical companies find Piracetam suppliers?

Companies can identify potential suppliers through pharmaceutical industry directories, API manufacturers, established distributors, industry trade networks, regulatory databases, and direct manufacturer qualification. Supplier selection should include quality, regulatory, technical, and commercial due diligence.

Is Piracetam suitable for consumer supplement marketing?

Regulatory treatment varies by country, and suppliers should not assume that pharmaceutical authorization in one market permits dietary-supplement marketing elsewhere. In the United States, FDA enforcement materials specifically addressed piracetam products marketed as dietary supplements.

ООО FARM LYUKS INVEST
ООО GRAND PHARM TRADE
CÔNG TY TNHH LIÊN DOANH STELLAPHARM CHI NHÁNH 1
CÔNG TY TNHH XUẤT NHẬP KHẨU Y TẾ DELTA
CÔNG TY CỔ PHẦN DƯỢC PHẨM TRUNG ƯƠNG CODUPHA
CÔNG TY CỔ PHẦN TẬP ĐOÀN DƯỢC PHẨM VÀ THƯƠNG MẠI SOHACO
ООО HURSHIDA ENTER DELUX
DR REDDY S LABORATORIES LTD
PT FARMASIA INOVASI MEGATRADING
OOO ASTOR ALLIANCE
RUSKIN CHEMIPHARM
CÔNG TY CỔ PHẦN TRAPHACO
SQUARE PHARMACEUTICALS PLC CHANGED
GLITZ PHARMA
GRUNENTHAL DE MEXICO SA DE CV
TATARASA PRIMATAMA
CÔNG TY CỔ PHẦN DƯỢC PHẨM HÀ TÂY
CÔNG TY TNHH NUTRI PHARMA USA
CÔNG TY CỔ PHẦN DƯỢC PHẨM CPC1 HÀ NỘI
CÔNG TY CỔ PHẦN FRESENIUS KABI VIỆT NAM
UCB PHARMA ANONIM SIRKETI
GORANG INTERNATIONAL
ZYDUS PHARMACEUTICALS MEXICO SA DE CV
LLC GRAND PHARM TRADE
PRODUCTOS FARMACEUTICOS SA DE CV
PT GLOBAL CHEMINDO MEGATRADING
CÔNG TY CỔ PHẦN THƯƠNG MẠI DƯỢC PHẨM QUỐC TẾ PHÚC ĐAN
GRAND PHARM TRADE
M S THE SCHAZOO PHARMACEUTICAL LABORATORIES PVT LTD
PT BERNOFARM
SUN RISE ENTERPRISES
ООО CURATIO PHARM
BIOTEK FARM
CHI NHÁNH CÔNG TY TNHH GLANDCORE
CÔNG TY CỔ PHẦN THƯƠNG MẠI VIỆT UY
MEROS PHARM
OOO GRAND PHARM TRADE
SALES Y MATERIAS PRIMAS S DE RL DE CV
SIGMA ALDRICH QUIMICA S DE RL DE CV
CÔNG TY CỔ PHẦN DƯỢC THIẾT BỊ Y TẾ ĐÀ NẴNG
DEL TRADE INTERNATIONAL PRIVATE LIMITED
G C CHEMIE PHARMIE LIMITED
LLOYD LABORATORIES INC
MICRO LABS LIMITED
OOO FARM LYUKS INVEST
VAKSINA HEALTHCARE LTD
ООО NOVOTEK
ООО XASAN XUSAN FARM
CÔNG TY CỔ PHẦN PYMEPHARCO
CÔNG TY TNHH HÓA DƯỢC TOÀN PHÚC
INSPIRA BIO PHARM PRIVATE LIMITED
LABORATORIOS FARMA SA
OOO MEROS PHARM
THE SCHAZOO PHARMACEUTICAL LABORATORIES PVT LTD
ИП ООО ASKLEPIY
CÔNG TY CỔ PHẦN DƯỢC PHẨM TRUNG ƯƠNG I PHARBACO
CÔNG TY CỔ PHẦN HÓA CHẤT GLOBAL HUB
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
CÔNG TY TRÁCH NHIỆM HỮU HẠN IMCD VIỆT NAM
HIKAL LIMITED
SUN PHARMA LABORATORIES LIMITED
АК ДОРИ ДАРМОН
CÔNG TY CỔ PHẦN DƯỢC HẬU GIANG
CÔNG TY CỔ PHẦN DƯỢC VẬT TƯ Y TẾ THANH HOÁ
CÔNG TY CỔ PHẦN KOREA UNITED PHARM INT L
CÔNG TY TNHH DƯỢC PHẨM Á MỸ
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
FAGUSAL
LLC MEROS PHARM
NEOLPHARMA SA DE CV
OOO BIOTEK FARM
OOO GENESIS PHARMA
PARAM PHARMA
SIGMA ALDRICH CHEMICALS PRIVATE LIMITED
TOKYO CHEMICAL INDUSTRY INDIA PRIVATE LIMITED
ADDLERMED LLC
CENTRAL DRUG HOUSE
CÔNG TY CỔ PHẦN DƯỢC PHẨM ME DI SUN
CÔNG TY CỔ PHẦN DƯỢC PHẨM MINH DÂN
CÔNG TY CỔ PHẦN DƯỢC PHẨM VIỆT HÀ
CÔNG TY CỔ PHẦN DƯỢC TRUNG ƯƠNG MEDIPLANTEX
CÔNG TY CỔ PHẦN HÓA DƯỢC QUỐC TẾ HÀ NỘI
CÔNG TY CỔ PHẦN TMDV THĂNG LONG
CÔNG TY TNHH MTV NOVALAB
CÔNG TY TNHH MỘT THÀNH VIÊN DƯỢC PHẨM VRT
CÔNG TY TNHH VẬN TẢI XUẤT NHẬP KHẨU PHÚ CƯỜNG
JSC GRAND PHARM TRADE
MATERIA PHARMACEUTICA INTERNACIONAL SA DE CV
OOO DENTAFILL PLYUS
OOO YOUNG PHARM
PHILGEN PHARMACEUTICALS INC
PRATISTHA PHARMA
TOP TRADING TOPTRA CIA LTDA
ZYDUS LIFESCIENCES LIMITED
ИП ООО SERENE HEALTHCARE
AMBICA INT L CORP
AMBICA INTERNATIONAL CORPORATION
BROWN BURK PHILIPPINES INC
CALIPH PHARMACEUTICALS PVT LTD
CONSOL MANAGEMENT AND SHIPPING ULUS
CÔNG TY CỔ PHẦN KHOA HỌC CÔNG NGHỆ T T
CÔNG TY TNHH HÓA DƯỢC PHẨM PHƯƠNG PHÚC
ECO LEК EXCELLENCE
GLOBAL PHARMACEUTICALS PVT LTD
JUAN DANIEL ZAPATA ZAPATA
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORYPRIVATE LI
MEDI PHARMA DRUG HOUSE
O HERVANARIO S DE RL
OOCL LOGISTICS CHINA LIMITED DALIAN BRANCH
OOO FAGUSAL
PIER17 PANAMA INCORPORATED
SAVINO DEL BENE POLAND SP Z O O
SMP PREMIUM PHARM
THE IBN SINA PHARMACEUTICAL
WELMED PHARMACEUTICAL PRIVATE LIMITED
ООО PHARMAXI
СП ООО JURABEK LABORATORIES
ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED
ADVANCED CHEMICAL INDUSTRIES LTD
ARHAM DRUGS AND CHEMICALS PRIVATE LIMITED
ARSOJEANTA SOCIEDAD ANONIMA
BANGLADESH LABWARE CORPORATION
CEFA CENTRAL FARMACEUTICA SOCIEDAD ANONIMA
CÔNG TY CỔ PHẦN DƯỢC PHẨM BOSTON VIỆT NAM
CÔNG TY CỔ PHẦN DƯỢC VẬT TƯ Y TẾ HẢI DƯƠNG
CÔNG TY TNHH LIÊN DOANH HASAN DERMAPHARM
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
CÔNG TY TNHH XUẤT NHẬP KHẨU QUỐC TẾ CAMEL
FARM LYUKS INVEST
IMCD MEXICO SA DE CV
INDUKERN DE COLOMBIA S A S
LLC BIOTEK FARM
MERCK SA
MICRO SIN S R L
OOCL LOGISTICS CHINA LIMITED SHENYANG BRANCH
PT GUARDIAN PHARMATAMA
PT IFARS PHARMACEUTICAL LABORATORIES
PT TRIFA RAYA LABORATORIES
STELLAPHARM J V CO LTD
ULTRA INTERNATIONAL
VEM ILAC SANAYI VE TICARET ANONIM SIRKETI
WELMED PHARMACEUTICALS PVT LTD
ООО ADDLERMED
ACCULIFE PHARMA LTD
ADA ECZA DEPOSU ILAC SAGLIK MEDIKAL LOJISTIK INSAAT ITHALAT VE IHRACAT LIMITED SIRKETI
ADVANCED CHEMICAL INDUSTRIES PLC
ASR KIMYO INVEST
CINCHONA BIOSCIENCES
CROWLEY LOGISTICS
CRYSTOLITE PHARMACEUTICALS
CÔNG TY CỔ PHẦN DƯỢC DANAPHA
CÔNG TY CỔ PHẦN DƯỢC PHÚC THÁI
CÔNG TY CỔ PHẦN DƯỢC PHÚC VINH
CÔNG TY CỔ PHẦN DƯỢC PHẨM BẾN TRE
CÔNG TY CỔ PHẦN DƯỢC PHẨM EURO SANTÉ
CÔNG TY CỔ PHẦN DƯỢC PHẨM KHÁNH HÒA
CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU Y TẾ THÀNH PHỐ HỒ CHÍ MINH
CÔNG TY DƯỢC PHẨM VÀ THƯƠNG MẠI PHƯƠNG ĐÔNG TNHH
CÔNG TY TNHH SẢN XUẤT DƯỢC PHẨM MEDLAC PHARMA ITALY
DALLAS S A
DRUG INTERNATIONAL LIMITED
FARMALITE TRADING CO LTD
FYNK PHARMACEUTICALS
GLOBAL PHARMACEUTICALS PAKISTAN
GLOBAL PHARMACEUTICALS PVT LIMITED
IMCD VIETNAM COMPANY LIMITED
INDUSTRIAS GAFFEL MX INTL SA DE CV
JSC BIOTEK FARM
JSC NSD GROUP TIB
KIMIA TRADING LTDA
LABORATORIO GENERICOS SA
LLC NIKA PHARM
M S GLOBAL PHARMACEUTICALS PAKISTAN
MEDIOFARM
MEDLIFE
NANDLAL BANKATLAL PRIVATE LIMITED
NANO PHARMACEUTICALS
OA J PHARMACEUTICALS LIMITED
OBSONS PHARMACEUTICALS
OOO ASR KIMYO INVEST
OOO OSON FARM
OPSONIN PHARMA LIMITED
PALAZZO PANCIER RONALDO
PIER17 PANAMA INC
PJSC SINTEZ
PRONAQUIM SA DE CV
PT LAPI LABORATORIES
QUIMICA FINA SA
RENIE CHEMIST LIMITED
RESEARCH PHARMACEUTICAL S A
RODRIGUEZ AGUILAR RICARDO SEGISMUNDO
SANOFI HEALTHCARE INDIA PRIVATE LIMITED
SIGMA ALDRICH BRASIL LTDA
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
TIGAKA DISTRINDO PERKASA
TUTEUR SOCIEDAD ANONIMA
UNIGREEN MARINE S A
ZUNECA INCORPORATED
АТ КИЇВМЕДПРЕПАРАТ 01032 М КИЇВ ВУЛ САКСАГАНСЬКОГО 139
ООО CHEMO LAB
ООО DELPHARM
ООО MEROS PHARM
ООО ZUMA PHARMA
ПАО СИНТЕЗ
AHMET OZYURT
AMARI TRADE ALLIANCE LLP
ANALYTICA CHEMIE INC
AQUATIC REMEDIES LIMITED
BELTAMOZHSERVICE RUP MINSK BRANCH P P JSC BORISOVSKY PLANT OF MEDICATIONS
BIOCKRODT PHARMA
BIOFARMA ILAC SANAYI VE TICARET ANONIM SIRKETI
BORISOVSKIY ZAVOD MEDICINSKIKH PREPARATOV OPEN JOINT
CADIEP DISTRIB S A S
CANONPHARMA PRODUCTION
CARAWAY PHARMACEUTICAL
CHEMHUB TECHNOLOGIES INC
CHEMO LAB
CHEMO SA DE CV
COMPAÃIA FARMACEUTICA SOCIEDAD ANONIMA
COMPAÑIA FARMACEUTICA SOCIEDAD ANONIMA
CÁ NHÂN TỔ CHỨC KHÔNG CÓ MÃ SỐ THUẾ
CÔNG TY CP DƯỢC PHẨM AGIMEXPHARM
CÔNG TY CỔ PHẦN ASTA HEALTHCARE USA
CÔNG TY CỔ PHẦN DƯỢC PHẨM SOHA VIMEX
CÔNG TY CỔ PHẦN DƯỢC PHẨM TV PHARM
CÔNG TY CỔ PHẦN DƯỢC VÀ THIẾT BỊ Y TẾ T N T
CÔNG TY CỔ PHẦN DƯỢC ĐỒNG NAI
CÔNG TY CỔ PHẦN HÓA CHẤT Á CHÂU
CÔNG TY CỔ PHẦN HÓA DƯỢC DƯỢC PHẨM I
CÔNG TY CỔ PHẦN HÓA DƯỢC PHẨM MEKOPHAR
CÔNG TY CỔ PHẦN VẬT TƯ KỸ THUẬT ĐÔNG DƯƠNG
CÔNG TY TNHH DRP INTER
CÔNG TY TNHH THƯƠNG MẠI DỊCH VỤ VIỆT HỒNG
CÔNG TY TNHH THƯƠNG MẠI H B C
CÔNG TY TNHH TMDV VẬN TẢI THỊNH SÁNG
DAIRA FARM LLC
DELTA IMPORT EXPORT MEDICAL CO LTD
DENTAFILL PLYUS LLC
DHL EXPRESS MEXICO SA DE CV
DONGLUN LIMITED
DP WORLD LOGISTICS CHEMICAL GERMANY
DP WORLD LOGISTICS CHEMICAL GERMANY GMBH
DR REDDY S LABORATORIES LIMITED
DROGUERIA SAPORITI S A C I F I A
DUSTI FARM LLC
ELCON DRUGS AND FORMULATIONS LIMITED
ERAYFARM LLC
ESPECIALIDADES QUIMICAS APOTECARIAS AMN
ESPECIALIDADES QUIMICAS APOTECARIAS AMN S A
EUROLAB S A
FAREVA VILLA RICA SAS
FARMACIA DE ESPECIALIDADES HOSPITALARIAS
FLAMINGO PHARMACEUTICALS LIMITED
GENERAL IMPORT COMPANY INDIA PRIVATE LIMITED
GENESIS PHARMA
GENOME PHARMACEUTICALS PVT LIMITED
GLOBAL PHARMACEUTICALS PRIVATE LTD
GRACURE PHARMACEUTICALS LIMITED
IMEX OVERSEAS
INTERCARGO PANAMA S A
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
INTERSANA PHARMACEUTICAL PTY LTD
JINAY PHARMACEUTICALS PRIVATE LIMITED
JSC ASTOR ALLIANCE
JSC DENTAFILL PLYUS
JSC FAGUSAL
JSC GENESIS PHARMA
JSC MEROS PHARM
JSC TASH LAB AGENCY
JV JURABEK LABORATORIES LTD
KYRGYZFARMATION GP COMPANY
LABORATORIOS PISA SA DE CV
LLC ALTA
LLC ASTOR ALLIANCE
LLC BI LAYF
LLC FARM LYUKS INVEST
LLC LLC JURABEK LABORATORIES
LLC MADAD FARM
LLC MEDIOFARM
LLC MERRYMED FARM
LLC NSD GROUP TIB
LLC PHARM SECTOR
LLC SERENE HEALTHCARE
LLC TOJVARZ
LLC VAGA FARM
LLC VELPHARM
LTD COMPANY OF SIFAT FARMA
LYMENS MEDICAL SUPPLY LIMITED
M S CARAWAY PHARMACEUTICALS
M S GLAXOSMITHKLINE PAKISTAN LIMITED
M S MEDISURE LABORATORIES PAKISTAN PVT LTD
MDLD INTERCHEMICAL INDUSTRIES INC
MEDISURE LABORATORIES PAKISTAN PVT LTD
MEROS PHARM LLC
MERRYMED FARM
MIGEL LADON
MISSION FOR ESSENTIAL DRUGS AND SUPPLIES MEDS
MOLECULAS FARMACEUTICAS S A S
NAMPHARM PTY LTD
NEOLSYM SA DE CV
NL NEUTRAL LOGISTICS RNC
NOVECY PHARMACY CC NP O BOX
NOVELL PHARMACEUTICAL LABORATORIES
NS SUPPLIER
OOO LEKINTERKAPS
OOO MEDIOFARM
OOO SALOMATLIK A
OOO XASAN XUSAN FARM
OPELLA HEALTHCARE BRAZIL LTDA
OSEL ILAC SANAYI VE TICARET ANONIM SIRKETI
PANAMA CONSOLIDATION SERVICES INCORPORATED
PHARMACEUTICAL CARE
PHARMAXI
PHITOFARMA S A
PRIVATE LIMITED COMPANY SERENE HEALTHCARE
PT DEXA MEDICA
PT KINAS GLOBAL INDONUSA
PT MERCK CHEMICALS AND LIFE SCIENCES
PT MERCK CHEMICALS LIFE SCIENCES
PT SATYA SAMITRA NIAGATAMA
PT TATARASA PRIMATAMA
PT TIGAKA DISTRINDO PERKASA
PT YINUO PHARMCHEM INDONESIA
QUIMICA ALKANO SA DE CV
RADIKS
RAHMAN SEHAT LTD
RING INTERNATIONAL TRANSPORT JSC
S A CARGO SERVICES S A
SAMO LLC
SAYNS LLC
SIGMA
SIGMA ALDRICH QUIMICA LIMITADA
STAR CARGO SERVICES S A
SUPER DORIXONA XIZMATI 999
SZABO SA
TECNOQUIMICAS S A
THE BELTAMOZHSERVICE RUP MINSK BRANCH FOR UNITARY ENTERPRISE MINSKINTERKAPS
TORRENT PHARMACEUTICALS LTD
TRIGON PHARMACEUTICALS PVT LIMITED LAHORE
TRIGON PHARMACEUTICALS PVT LTD
TUKEI S A
U S F S R L
WELMED PHARMACEUTICAL INDUSTRIES PVT LTD
WILSHIRE LABORATORIES PVT LTD
WILSHIRE LABORATRIES PRIVATE LIMITED
WINLET PHARMACEUTICALS PRIVATE LIMITED
WINLET PHARMACEUTICALS PVT LTD
XL LABORATORIES PRIVATE LIMITED
ZAFA PHARMACEUTICAL LABORATORIES PRIVATE LIMITED
ZAFA PHARMACEUTICAL LABORATORIES PVT LIMITED
ОАО ДАЛЬХИМФАРМ
ООО ASR KIMYO INVEST
ООО GOLD DISHES
ООО JAMXUR PHARM SERVIS
ООО NAVBAHOR SANOAT
ООО NEO FARM
ООО PHARM SPECTR
ООО RADIKS
ООО КОМПАНИЯ ДЕКО
ПРИВАТНЕ АКЦІОНЕРНЕ ТОВАРИСТВО ЛЕКХІМ 01033 М КИЇВ ВУЛ ШОТА РУСТАВЕЛІ 23 УКРАЇНА
СП OOO REKA MED FARM
СП ООО REKA MED FARM
СП ООО SAMARKAND ENGLAND ECO MEDICAL
СП ООО UZGERMED PHARM
ТОВ ІСТФАРМА ПРOВ КРИНИЧНИЙ 10 61022 М ХАРКІВ УКРАЇНА
ТОВ ФАРМАСЕЛ 07408 ВУЛ ПРОРІЗНА БУД №3 СЕЛО КВІТНЕВЕ БРОВАРСЬКИЙ Р Н КИЇВСЬКА
ТОО DPB NEW BRANDS
ТОО SMARTCHEM
ЧЛ PULATBIEKOV MURODBEK UMARBEKOVICH

Conclusion

A successful Piracetam Global Buyers List should be more than a collection of pharmaceutical company names. The most valuable buyer database identifies qualified pharmaceutical manufacturers, API distributors, generic-drug companies, CMOs/CDMOs, and legitimate research organizations, while also considering the regulatory requirements of each destination market.

For suppliers, the strongest B2B strategy combines accurate product information, transparent quality documentation, market-specific regulatory awareness, reliable supply capabilities, and professional buyer qualification.

Because piracetam’s regulatory status differs across jurisdictions, every potential transaction should be evaluated according to the buyer’s intended application and applicable national pharmaceutical laws. This compliance-first approach helps create a more trustworthy, sustainable, and search-engine-friendly B2B presence.